NCT07933497
M4 Receptor PET Radioligand Validation Study in Healthy Adults
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Regional brain volume of distribution (VT) of ABBV-112i across brain regions
Timeframe: Up to Approximately Up to Day 1
Arms and interventions
[11C]ABBV-112iExperimental
Participants will receive two single intravenous bolus doses of \[11C\]ABBV-112i, with each dose followed by up to approximately 90 minutes dynamic PET scan.
Drugs: [11C]ABBV-112i